Bromazolam 5mg “Counterfeit Xanax” Pressies

Bromazolam is a triazolobenzodiazepine which was first synthesised in 1976, but was never marketed. It was first definitively identified by the EMCDDA in Sweden in 2016.

It is the bromo instead of chloro analogue of alprazolam and has similar sedative and anxiolytic side effects to it and other benzodiazepines.

Bromazolam is a non subtype selective agonist at the benzodiazepine site of GABA-A receptors, with a relatively strong binding affinity.

The “common” dosage range for recreational and habitual users of bromazolam was reported to be 3-5mg, suggesting its potency is similar although slightly weaker than alprazolam.